These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27857191)

  • 1. Deregulation of the miR-16-KRAS axis promotes colorectal cancer.
    You C; Liang H; Sun W; Li J; Liu Y; Fan Q; Zhang H; Yue X; Li J; Chen X; Ba Y
    Sci Rep; 2016 Nov; 6():37459. PubMed ID: 27857191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Liu X; Wang Y; Zhao J
    Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
    Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
    PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.
    Huang L; Wen C; Yang X; Lou Q; Wang X; Che J; Chen J; Yang Z; Wu X; Huang M; Lan P; Wang L; Iwamoto A; Wang J; Liu H
    Cell Death Dis; 2018 Feb; 9(3):271. PubMed ID: 29449544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
    Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
    J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells.
    Liu H; Liu J; Huo J; Li K; Li K; Guo H; Yang Y
    Oncol Rep; 2019 Dec; 42(6):2759-2767. PubMed ID: 31638218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
    Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS.
    Chen X; Lin ZF; Xi WJ; Wang W; Zhang D; Yang F; Li YF; Huo Y; Zhang TZ; Jiang YH; Qin WW; Yang AG; Wang T
    Cancer Med; 2019 Apr; 8(4):1694-1709. PubMed ID: 30791232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
    Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
    Fu X; Cui Y; Yang S; Xu Y; Zhang Z
    Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
    Liu Y; Liu R; Yang F; Cheng R; Chen X; Cui S; Gu Y; Sun W; You C; Liu Z; Sun F; Wang Y; Fu Z; Ye C; Zhang C; Li J; Chen X
    Mol Cancer; 2017 Mar; 16(1):53. PubMed ID: 28257633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
    Kang K; Zhang J; Zhang X; Chen Z
    Oncol Rep; 2018 Jan; 39(1):401-410. PubMed ID: 29115540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.